Risk factors of Alzheimer's disease among Iranian population

Current Alzheimer Research

Volumn 5, Issue 1, 2008, Pages 70-72

  Foroughan, Mahshid ^a,d   Farahani, Zia Ghaemmagham ^a   Shariatpanahi, Maryam ^b   Vaezinejad, Mehrak ^b   Kamerani, Ahmad Ali Akbari ^a   Sheikhvatan, Mehrdad ^c  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE   (Iran)

Author keywords

Alzheimer's disease; Diabetes mellitus; Hypertension; Risk factors; Smoking

Indexed keywords

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; IRAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; POPULATION RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; SOCIAL STATUS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; IRAN; MALE; MATCHED-PAIR ANALYSIS; REFERENCE VALUES; RISK FACTORS; TOBACCO USE DISORDER; VASCULAR DISEASES;

EID: 42149105624     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508783884594     Document Type: Article

References (26)

1. Gorelick PB. Prevention. In: Bowler JV, Hachinski V, eds. In: 'Vascular Cognitive Impairment. Preventable Dementia'. Oxford University Press. New York, NY,' p. 308-320 (2003).
2. Ritchie K, Lovestone S. The dementias. Lancet 360:1759 -1766 (2002).
3. Gorelick PB. Risk Factors for Vascular Dementia and Alzheimer Disease. Stroke 35: 2620-2622 (2004).
4. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937-1942 (1999).
5. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, et al. Risk of dementia among persons with diabetes mellitus: a population- based cohort study. Am J Epidemiol 145:301-308 (1997).
6. Peila R, Rodriguez BL, Launer LJ. Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies: The Honolulu-Asia. Aging Study Diabetes 51:1256-1262 (2002).
7. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 356:1627-1631 (2000).
8. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145 (1996).
9. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study Stroke 28:316-321 (1997).
10. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351:1840-1843 (1998).
11. Merchant C, Tang M-X, Albert S, Manly J, Stern Y, Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology 52:1408 (1999).
12. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483 (2002).
13. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease. Arch Intern Med 163:1524-1528 (2003).
14. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160 (2000).
15. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, et al. Cache County Investigators. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20:93-100 (2006).
16. Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 62:1047-51 (2005).
17. Messier C. Diabetes, Alzheimer's disease and apolipoprotein genotype. Exp Gerontol 38: 941-946 (2003).
18. Vogel T, Benetos A, Verreault R, Kaltenbach G, Kiesmann M, Berthel M. Risk factors for Alzheimer: towards prevention? Presse Med 35:1309-1316 (2006).
19. de Leeuw FE, van Norden AG, van der Flier WM, Olde Rikkert MG, Scheltens P. Alzheimer's disease and treatment of vascular risk factors. Ned Tijdschr Geneeskd 149:2844-2849 (2005).
20. Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. CNS Drugs 16:435-444 (2002).
21. Hassing LB, Johansson B, Nilsson SE, Berg S, Pedersen NL, Gatz M, et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr 14:239-248 (2002).
22. Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551-1555 (2006).
23. Cowppli-Bony P, Dartigues JF, Orgogozo JM. Vascular risk factors and Alzheimer disease risk: epidemiological studies review. Psychol Neuropsychiatr Vieil 4:47-60 (2006).
24. Almeida OP. Can we prevent Alzheimer's disease? Rev Bras Psiquiatr 27:264-265 (2005).
25. Fratiglioni L, Wang HX. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav Brain Res 113:117-120 (2000).
26. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20: 48-57 (1991).